Navigation Links
Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
Date:11/19/2007

life. Visit Bristol-Myers Squibb on the World Wide Web at http://www.bms.com.

Forward Looking

For sanofi-aventis

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include financial projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward- looking information and statements. These risks and uncertainties include risks that may arise from the outcome of any appeal, the adverse impact of generic product distributed into the market by Apotex, the potential launch of a generic clopidogrel bisulfate product by other entities, as well as those discussed or identified in the public filings with the SEC and the AMF made by sanofi-aventis, including those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Statements" in sanofi-aventis' annual report on Form 20-F for the year ended December 31, 2006. Other than as required by applicable law, sanofi-aventis does not undertake any obligation to update or revise any
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent
5. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
6. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
7. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
8. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
9. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...CHOCORDOVA,Calif.,Nov.25/PRNewswire/--AMPACFineChe...tion(Nasdaq: APFC )announcedtodaythatitreceivedthe...ttheAnnualStatewideEnvironmentalSummit,sponsoredby...(CMTA),theIndustrialEnvironmentalAssociation(IEA)a...inSanDiego.Thisisthemostprestigiousawardavailablef...
(Date:11/25/2009)...YORK,Nov.25/PRNewswire/--Reportlinker.comannounces...gue: ,, UnitedStatesDentalDevicesMarketAnalysi...r.com/p0158733/United-States-Dental-Devices-Market...StatesDentalDevicesMarketAnalysisandForecaststo201...rceforin-depthinformationanddatarelatingtotheUSden...
(Date:11/25/2009)...TBRUNSWICK,N.J.,Nov.25/PRNewswire/--SwissrayIntern...iography( ddR )systems,announcedtodaythatitsoperat...ngtermviewtowardsgrowingSwissray,smedicalimagingbr...property,aswellascontractsandinventory.After25year...extleveloftechnologicaladvancementswithstableandst...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Swissray International Announces New Ownership 2Archi Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull Through Reporting Capabilities 55826 1Archi Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull Through Reporting Capabilities 55826 2Mark W Parrish Joins Mylans Board of Directors 13758 1Mark W Parrish Joins Mylans Board of Directors 13758 2Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 1Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 2Jacobs Receives Contract for San Francisco General Hospital and Trauma Center Rebuild Program 55823 3
... in Advanced Cancer Patients, ROCKVILLE, Md., Apr...nical-stage pharmaceutical company developing,ther...ory diseases, today,announced that it has commence...ith its oral cell cycle inhibitor, MKC-1, in patie...clinical trial will be conducted at the,University...
... funding CoAxia,s studies of its NeuroFlo(TM) ...Stroke, MINNEAPOLIS, April 1, 2008 CoAxia(TM), I...g of an additional $11.5M financing,from current i...ngoing,clinical trials. The investment is an exten...allow CoAxia to continue its SENTIS pivotal FDA tr...
Other Medicine Technology:EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 2EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 3EntreMed Commences Continuous Dosing Clinical Trial For MKC-1 4CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors 2
(Date:11/25/2009)... SANFRANCISCO,Nov.25/PRNewswire/--TheBayAreaAirQua...nter Spare the Air Alert forThursday...irelogsoranyothersolidfuel,bothindoorsandoutdoors....airqualitytomorrow,"saidJackBroadbent,executiveoff...orespectthehealthoftheirneighborsandfellowcommunit...
(Date:11/25/2009)...ortuitous discovery that grew out of a collaborati...entially offer hope to the nearly 10 million Ameri... , Also known as hardening of the arteries, p...rculatory problem in which narrowed arteries reduc...ered a red flag for vascular disease, heart attack...
(Date:11/25/2009)... Evaluation and treatment clinic... Woodstock (Vocus) November 25, 2009 -- Centeg... vaccines and H1N1 vaccine shots at four Centegra ...er shipment of vaccine has arrived. The clinics ar... and McHenry and will be open as follows: , &n...
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/-- MISSIONSkincare ...lionforSt.Jude.AspartofGNC,sannualSt.Jude Thanksan...SIONSkincare,s new SUPER-C(TM)LipBalm willbedona...tunitytomakea$1,$5or$10donationatcheckoutatoneofth...emorethan$1millionforSt.Judeduringtheir2009 Thanks...
(Date:11/25/2009)...g used to treat colorectal cancer also can reverse...first-line therapy for the disease, researchers at...week. , Mntrier,s disease causes thickening of th...d vomiting, as well as anemia and swelling in the ...at increased risk for gastric cancer. Previously, ...
Breaking Medicine News(10 mins):Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2
...$20,000 Nationwide Scholarship, Competition with C...itcom, Rules of Engagemen...c. announced today the launch of the 2008 Calm-A-S...,s young people,to the health-related benefits of ...
...ional,ocean conservation group based in Washington...ination for many years. Consuming big fish high on...osed to mercury, a heavy,metal that can cause neur...ercury-free (and worry-free):, -- Choose low-me...
...f 30% of infected patients in U.K., researchers sa...tish research into Steno, one the most recent "sup... has an incredible ability to resist antibiotics a... around taps and shower heads, and can be transmit...
...ofit remains stable; net loss per ...in Canadian dollars unless otherwise noted), BELL...e Life Sciences,Inc. (TSX: BNC), a research-based,...1, 2008., "One highlight of our third quarter was...
... - DRAXIS Health Inc. (TSX: DAX),(NASDAQ: DRAX ) ...hree,months ended March 31, 2008. Revenues and ear...se in the first quarter of 2007 as a result of low...the,first quarter of 2007 of non-recurring items a...
...a-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical...aceutical" or "the Company"), a leading manufactur... grade glucose products in China and glucose,and s...0 a.m. Eastern Time on Friday, May 16, 2008 to dis...
Other Medicine News:Health News:Drink Tea. Win $20,000. Experience the 'Calm-A-Sutra of Tea' 2Health News:Drink Tea. Win $20,000. Experience the 'Calm-A-Sutra of Tea' 3Health News:Amber Valletta on Preventing Mercury Exposure 2Health News:Amber Valletta on Preventing Mercury Exposure 3Health News:Steno 'Superbug' Genome Shows Extreme Drug Resistance 2Health News:Bioniche Reports Fiscal 2008 Third Quarter 2Health News:Bioniche Reports Fiscal 2008 Third Quarter 3Health News:Bioniche Reports Fiscal 2008 Third Quarter 4Health News:Bioniche Reports Fiscal 2008 Third Quarter 5Health News:Bioniche Reports Fiscal 2008 Third Quarter 6Health News:Bioniche Reports Fiscal 2008 Third Quarter 7Health News:Bioniche Reports Fiscal 2008 Third Quarter 8Health News:Bioniche Reports Fiscal 2008 Third Quarter 9Health News:Bioniche Reports Fiscal 2008 Third Quarter 10Health News:Bioniche Reports Fiscal 2008 Third Quarter 11Health News:Bioniche Reports Fiscal 2008 Third Quarter 12Health News:Bioniche Reports Fiscal 2008 Third Quarter 13Health News:Bioniche Reports Fiscal 2008 Third Quarter 14Health News:Bioniche Reports Fiscal 2008 Third Quarter 15Health News:DRAXIS Health Reports Results for the First Quarter of 2008 2Health News:DRAXIS Health Reports Results for the First Quarter of 2008 3Health News:DRAXIS Health Reports Results for the First Quarter of 2008 4Health News:DRAXIS Health Reports Results for the First Quarter of 2008 5Health News:DRAXIS Health Reports Results for the First Quarter of 2008 6Health News:DRAXIS Health Reports Results for the First Quarter of 2008 7Health News:DRAXIS Health Reports Results for the First Quarter of 2008 8Health News:DRAXIS Health Reports Results for the First Quarter of 2008 9Health News:DRAXIS Health Reports Results for the First Quarter of 2008 10Health News:DRAXIS Health Reports Results for the First Quarter of 2008 11Health News:DRAXIS Health Reports Results for the First Quarter of 2008 12Health News:DRAXIS Health Reports Results for the First Quarter of 2008 13Health News:DRAXIS Health Reports Results for the First Quarter of 2008 14Health News:DRAXIS Health Reports Results for the First Quarter of 2008 15Health News:DRAXIS Health Reports Results for the First Quarter of 2008 16Health News:DRAXIS Health Reports Results for the First Quarter of 2008 17
Caspar Cervical Retractor (Lamina Spreader)
Cervical Retractor With Double Finger Hold
Scoville Cervical Disc Retractor
Codman Cervical Retractor
Medicine Products: